Hot stocks: Brokerage view on Apollo Hospitals, Gujarat Gas, JSPL, Polycab and Tata Steel

 07 Nov 2024 08:49 AM

Brokerage firms have varied recommendations: JP Morgan rates Apollo Hospitals overweight, Citi downgrades Gujarat Gas, Morgan Stanley is positive on JSPL, while Jefferies gives a buy rating to Polycab.

POLYCAB INDIA: CO WINS ORDER WORTH 1,549 CR RUPEES

 07 Nov 2024 07:26 AM

POLYCAB INDIA: CO WINS ORDER WORTH 1,549 CR RUPEES

GAIL, Polycab among 5 stocks with long buildup

 06 Nov 2024 02:20 PM

A long buildup occurs when open interest and trading volumes grow alongside an increase in the underlying stock price in the Futures and Options segment, signaling a bullish market trend.

POLYCAB INDIA: CO EMERGES AS THE LOWEST BIDDER (L1) FROM BSNL; CONTRACT WORTH 4099 CR RUPEES

 06 Nov 2024 09:09 AM

POLYCAB INDIA: CO EMERGES AS THE LOWEST BIDDER (L1) FROM BSNL; CONTRACT WORTH 4099 CR RUPEES

POLYCAB INDIA: CO EXPECTS TO ACHIEVE A PROJECT LEAP GOAL OF RUPEES 200B REVENUE A YEAR AHEAD OF THE TARGETED FY26 TIMELINE - CONCALL UPDATE

 21 Oct 2024 09:15 AM

POLYCAB INDIA: CO EXPECTS TO ACHIEVE A PROJECT LEAP GOAL OF RUPEES 200B REVENUE A YEAR AHEAD OF THE TARGETED FY26 TIMELINE - CONCALL UPDATE

Polycab shares slip 7% after Q2 results. What should investors do?

 18 Oct 2024 10:47 AM

Polycab Share Price: Polycab India's shares fell nearly 7% despite a 3.5% YoY net profit increase, driven by strong revenue growth but rising expenses. Analysts remain positive, with 'Buy' ratings from Motilal Oswal and Nuvama.

POLYCAB INDIA: Q2 EBITDA 6.31B RUPEES VS 6.1B (YOY); EST 6.49B || Q2 EBITDA MARGIN 11.49% VS 14.44% (YOY); EST 13%

 17 Oct 2024 05:43 PM

POLYCAB INDIA: Q2 EBITDA 6.31B RUPEES VS 6.1B (YOY); EST 6.49B || Q2 EBITDA MARGIN 11.49% VS 14.44% (YOY); EST 13%

POLYCAB INDIA: Q2 REVENUE 55B RUPEES VS 42.2B (YOY)

 17 Oct 2024 05:43 PM

POLYCAB INDIA: Q2 REVENUE 55B RUPEES VS 42.2B (YOY)

POLYCAB INDIA: Q2 CONS NET PROFIT 4.4B RUPEES VS 4.3B (YOY); EST 4.47B; 3.95B (QOQ)

 17 Oct 2024 05:43 PM

POLYCAB INDIA: Q2 CONS NET PROFIT 4.4B RUPEES VS 4.3B (YOY); EST 4.47B; 3.95B (QOQ)